Nanotechnology in the UK – judging the government’s performance

The Royal Society report on nanotechnology – Nanoscience and nanotechnologies: opportunities and uncertainties – was published in 2004, and the government responded to its recommendations early in 2005. At that time, many people were disappointed by the government response (see my commentary here); now the time has come to judge whether the government is meeting its commitments. The body that is going to make that judgement is the Council for Science and Technology. This is the government’s highest level advisory committee, reporting directly to the Prime Minister. The CST Nanotechnology Review is now underway, with a public call for evidence now open. Yesterday I attended a seminar in London organised by the working party.

I’ve written already of my disappointment with the government response so far, for example here, so you might think that I’d be confident that this review would be rather critical of the government. However, close reading of the call for evidence reveals a fine piece of “Yes Minister” style legerdemain; the review will judge, not whether the government’s response to the Royal Society report was itself adequate, but solely whether the government had met the commitments it made in that response.

One of the main purposes of yesterday’s seminar was to see if there had been any major new developments in nanotechnology since the publication of the Royal Society report. Some people expressed surprise at how rapid the introduction of nanotechnology into consumer products had been, though as ever it is difficult to judge how many of these applications can truly be described as nanotechnology, and equally how many other applications are in the market which do involve nanotechnology, but which don’t advertise the fact. However, one area in which there has been a demonstrable and striking proliferation is in nanotechnology road-maps, of which there are now, apparently, a total of seventy six.

Was Feynman the founder of nanotechnology?

Amidst all the controversy about what nanotechnology is and isn’t, one thing that everyone seems to agree on is the visionary role of Richard Feynman as the founding father of the field, through his famous lecture, There’s plenty of room at the bottom. In a series of posts I made here a year or so ago (Re-reading Feynman Part 1, Part 2, Part 3), I looked again, with the benefit of hindsight, at what Feynman actually said in this lecture, in the light of the way nanoscience and technology has developed. But does the claim that this lecture launched nanotechnology stand up to critical scrutiny?

This question was considered in a fascinating article by Chris Toumey called Apostolic Succession (PDF file). The article, published last year in Caltech’s house science magazine (just as Feynman’s original lecture was), takes a cool look at the evidence that might underpin the claim that “Plenty of Room at the Bottom” really was the foundational text for nanotechnology. The first place to look is in citations – occasions when the article was cited by other writers. Perhaps surprisingly, Plenty of Room was cited just 7 times in the two decades of the 60’s and 70’s, and the annual citation rate didn’t get into double figures until 1992. Next, Toumey directly questioned leading figures from nanoscience on the degree to which they were influenced by the Feynman lecture. The answers – from scientists of the standing of Binnig, Rohrer, and Eigler, Mirkin and Whitesides – were overwhelmingly negative. The major influence of the Feynman lecture, Toumey concludes, has been through the mediation of Drexler, who has been a vocal champion of the paper since coming across it around 1980.

Toumey draws three conclusions from all this. As he puts it, “The theory of apostolic succession posited that first there was “Plenty of Room”; then there was much interest in it; and finally that caused the birth of nanotechnology. My analysis suggests something different: first there was “Plenty of Room”; then there was very little interest in it; meanwhile, there was the birth of nanotechnology, independent of it; and finally there was a retroactive interest in it. I believe we can credit much of the rediscovery to Drexler, who has passionately championed Feynman’s paper.” As for why such a retroactive interest appeared, Toumey makes the obvious point that attaching one’s vision to someone with the genius, vision and charisma of Feynman is an obvious temptation. Finally, though, Toumey asks “how selective is the process of enhancing one’s work by retroactively claiming the Feynman cachet? “ The point here, and it is an important one, is that, as I discussed in my re-readings of Feynman, this lecture talked about many things and it requires a very selective reading to claim that Feynman’s musings supported any single vision of nanotechnology.

Toumey (who is from the centre for nanoScience & Technology Studies at the University of South Carolina) is an anthropologist by training, so it’s perhaps appropriate that his final conclusion is expressed in rather anthropological terms: “We can speculate about why “Plenty of Room” was rediscovered. Perhaps it shows us that a new science needed an authoritative founding myth, and needed it quickly. If so, then pulling Feynman’s talk off the shelf was a smart move because it gave nanotech an early date of birth, it made nanotech coherent, and it connected nanotech to the Feynman cachet.”

My thanks to Peter Rodgers for bringing this article to my attention.

In Australia

I’ve been to Australia for a brief trip, attending a closed public policy conference run by the Australian think-tank the Centre for Independent Studies. The terms of engagement of the conference prevent me from reporting on it in detail; it’s meant to be unreported and off-the-record. The attendance list was certainly a cut above the usual scientific conferences I go to; it included present and former cabinet ministers from the Australian and New Zealand governments, central bankers and senior judges, industry CEOs and prominent journalists.

A session of the conference was devoted to nanotechnology; I spoke, together with a couple of prominent Australian nanoscientists and the science correspondent of one of Australia’s major dailies. I was nervous about how I would be received, and I think many of the audience, more used to hearing about terrorism in Indonesia or commodity price fluctuations, were similarly nervous about whether they would find anything to interest them in such a specialised and futuristic sounding topic. In the event, I think, everyone was very pleasantly surprised at the success of the session and the lively debate it sparked.

I don’t want to divert this blog too much into discussing politics, but I can’t help observing that the tone of the meeting was a little bit more right wing than I am used to. The CIS clearly occupies rather a different part of think-tank space to my centrist friends in Demos, for example, and I regretted having left my Ayn Rand t-shirts at home. Nonetheless, I think it’s hugely important that science and technology do start to play a larger role in policy discussions.

A brief update

My frequency of posting has gone down in the last couple of weeks due to a combination of excessive busy-ness and a not wholly successful attempt to catch up with stuff before going on holiday. Here’s a brief overview of some of the things I would have written about if I’d had more time.

The Nanotechnology Engagement Group (which I chair) met last week to sketch out some of the directions of its second policy report, informed in part by an excellent workshop – Terms of Engagement – held in London a few weeks ago. The workshop brought together policy-makers, practitioners of public engagement, members of the public who had been involved in public engagement events about nanotechnology, and scientists, to explore the different expectations and aspirations these different actors have, and the tensions that arise when these expectations aren’t compatible.

The UK government’s funding body for the physical sciences, EPSRC, held a town meeting to discuss its new draft nanotechnology strategy last week. About 50 of the UKs leading nanoscientists attended; To summarise the mood of the meeting, people were pleased that EPSRC was drawing up a strategy, but they thought that the tentative plan was not nearly ambitious enough. EPSRC and its Strategic Working Group on Nanotechnology (of which I am a member) will be revising the draft strategy in line with these comments and the result should be presented to EPSRC Council for approval in October.

The last two issues of Nature have much to interest the nanotechnologist. Nanotubes unwrapped introduces the idea of using exfoliated graphite as a reinforcing material in composites; this should produce many of the advantages that people hope for in nanotube composites (but which have not yet so far fully materialised) at much lower cost. Spintronics at the atomic level describes a very elegant experiment in which a single manganese atom is introduced as a substitutional dopant on a gallium arsenide surface using a scanning tunnelling microscope, to probe its magnetic interactions with the surroundings. This week’s issue also includes a very interesting set of review articles about microfluidics, including pieces by George Whitesides and Harold Craighead, to which there is free access.

Rob Freitas has put together a website for his Nanofactory collaboration. Having complained on this blog before that my own critique of MNT proposals has been ignored by MNT proponents, it’s only fair for me to recognise that this site has a section about technical challenges which explicitly acknowledges such critiques with these positive words:
“This list, which is almost certainly incomplete, parallels and incorporates the written concerns expressed in thoughtful commentaries by Philip Moriarty in 2005 and Richard Jones in 2006. We welcome these critiques and would encourage additional constructive commentary – and suggestions for additional technical challenges that we may have overlooked – along similar lines by others.”

Finally, in a not totally unrelated development, the UKs funding council, EPSRC, will be running an Ideas Factory on the subject of Matter compilation via molecular manufacturing: reconstructing the wheel. The way this program works is that participants spend a week generating new ideas and collaborations, and at the end of it £1.45 million funding is guaranteed for the best proposals. I’ve been asked to act as the director of this activity, which should take place early in the New Year.

A round-up of nano-blogs

To mark the growing popularity of science-based blogs, here’s a quick roundup of some blogs devoted to nanotechnology. Nanotechnology means many things to different people, and this diversity of points of view is reflected in the wide variety of perspectives on offer in the blogs.

From the point of view of business and the financial markets, TNTlog comes from Tim Harper, of the European consulting firm Cientifica. His posting frequency has dropped off recently, which is a pity, since this is a blog that manages to be both entertaining and well-informed, with a healthy scepticism about some of the wilder claims made on behalf of the “nanotechnology industry”. The web-portal nanotechnology.com hosts a contrasting pair of blogs. blog | nano, by Darrell Brookstein, is at the shriller end of the nanobusiness spectrum, while Steve Edwards’s blog combines commentary on nano financial markets with the odd extract from his (rather good) book – The Nanotech Pioneers.

Among blogs written by academics, there are those that come from scientists working inside the field, and some from social scientists whose interests run more towards the social issues surrounding nanotechnology. In the first category we have Nanoscale Views, by academic nanophysicist Doug Natelson. This combines capsule reviews of new condensed matter preprints and conference reports with more general observations about life as a junior faculty, and is at quite a high technical level. Martyn Amos is a computer scientist; his blog covers issues such as synthetic biology and chemical computing. The authors of Molecular Torch seem to be keen to keep their identities quiet, but from what they cover I’m guessing they work in the field of nanochemistry, with a particular interest in quantum dots. If you want to know what Soft Machines is about, just look around.

From the social science side of things, David Berube’s Nanohype casts a sceptical eye on the scene, leavening fairly detailed commentary on various reports and conferences with his enjoyably acerbic humour. Nano|Public, Dietram Scheufele, similarly covers public engagement issues from an academic point of view. Nanotechbuzz by George Elvin, is more general in its coverage, which reflects the interests of its author, an architecture professor with interest the relationship between nanotechnology and design.

A couple of blogs reflect the views of those interested in Drexler’s vision of molecular nanotechnology. The current market leader in the faith-based end of this space is Responsible Nanotechnology, from the Center for Responsible Nanotechnology, aka Mike Treder and Chris Phoenix. This pair have the most impressive output in terms of sheer volume. Their analysis is predicated on the unsupported assertion that desktop nanofactories could be with us in 10-15 years; any dissent from this view is met, not with rational argument, but with accusations of bad faith or scientific fraud. Nanodot, from the Foresight Nanotech Institute’s Christine Peterson, represents the more acceptable face of Drexlerism, combining reporting on current nanoscience developments and commentary about social and economic issues, with discussion of longer-ranged prospects, albeit in a framework of thorough-going technological determinism.

Finally, we have a couple of blogs written by professional writers. Howard Lovy’s Nanobot was a useful source of nano- commentary, particularly strong on charting the influence of nanotechnology on popular culture, before Howard’s move to the darkside of public relations led to a quiet period. Nanobot has recently gently restarted. A very welcome newcomer is homunculus from my favourite science writer, Philip Ball. The scope of homunculus goes well beyond nanotechnology, covering aspects of chemistry and physics ranging from the application of statistical mechanics to financial markets to the historical links between chemistry and fine arts. His most recent post contains much of the useful background information that didn’t make it into his recent news piece for Nature about the potential neurotoxicity of nanoscale titania.

My apologies to anyone I’ve missed out.

Public engagement in theory and practise

Tuesday saw me both practising and preaching public engagement – I talked to about a hundred 15 year olds about nanotechnology in Sheffield in the morning, and then scooted to London to make a guest appearance in front of the Science and Society Strategy Panel of the Biotechnology and Biological Sciences Research Council, the body which doles out research funding on behalf of the UK government for those bits of biological science which are not directly clinically relevant. This panel represents the BBSRC’s first attempt to incorporate public engagement in their strategy setting; given the recent history of biotechnology in the UK it’s not surprising that many of the panel are veterans (from both sides) of the GM wars.

This is a relatively new committee, and they are still working out how their deliberations might actually have tangible impacts. The meeting had a wide-ranging discussion about the practicalities and realities of public engagement; one piece of work that they have recently commissioned, on public attitudes to ageing research, will interest transhumanists and life extension enthusiasts. Details will have to wait until the report, and the committee’s response to it, have been made public.

Ken Donaldson on nanoparticle toxicology

I’ve been running in and out of a three day course on nanotechnology intended for chemists working in the chemistry industry (Nanotechnology for Chemists), organised by me and my colleagues at Sheffield on behalf of the Royal Society of Chemistry. Yesterday I swapped from being a lecturer to being a pupil, to hear a lecture about nanoparticle toxicity, given by Ken Donaldson of the University of Edinburgh, the UK’s leading toxicologist specialising in the effects of environmental nanoparticles. This is a brief summary of his lecture as I understood it (all misunderstandings and misapprehensions are my fault, of course).

His lecture began with the disclaimer that most nanotechnology won’t pose a health risk at all; what’s at issue is the single class of free (i.e. not incorporated in a matrix, as happens in a nanocomposite material), manufactured, insoluble nanoparticles. Of the potential portals of entry – the lungs, the gut and the skin – he felt that the main danger was the lungs, so the main potential danger, both for industrial workers and users, was nanoparticles in the air.

It’s been known for a long time that particles cause lung disease; he gave a number of examples (illustrated by gruesome photographs), including coal miner’s lung, cancer and silicosis from quartz particles and asbestos. The latter causes a number of diseases, including mesothelioma, a particularly nasty cancer seen only in people exposed to asbestos, characterised by long latency period and with a uniformly fatal final outcome. So it’s clear that particles do accumulate in the lungs.

In terms of what we know about the effect of nanoparticle exposures, there are four distinct domains. What we know most about are the nanoparticles derived from combustion. We also know a fair amount about bulk manufactured particles, like titanium dioxide, which have been around a long time and which typically contain significant fractions of nanosized particles. Of course, the effects of nanoparticles used in medical contexts have been well studied. The final area is the least studied – the effect of engineered free nanoparticles.

So what can we learn from environmental nanoparticles? The origin of these particles is overwhelmingly from combustion; in the UK only 13% of exposure comes from non-combustion sources, usually the processes of natural atmospheric chemistry. The most important class of nanoparticles by far are those deriving from traffic exhaust, which account for 60% of exposure. These particles have a basic size of tens of nanometers, though they clump with time into micron sized aggregates, which are very easily respirable.

These particles have no problem getting deep within the lungs. Of the 40 nm particles, perhaps 30% can get to the very delicate tissues in the periphery of the lung, where they deposit very efficiently (smaller particles actually are less effective at getting to the lung as they tend to be taken up in the nose). The structures they interact with deep in the lung – the bronchal epithelial cells – are very small and fragile, and the distances separating airways from the blood are very small. Here the particles cause inflammation, which is essentially a defense reaction. We’re familiar with inflammation of the skin, marked by swelling – fluid bathes the region and white blood cells engulf damaged tissue and microbes, leading to pain, heat, redness and loss of function. Of course in the lung one can’t see the inflammation, and there are no pain receptors, so inflammation can be less obvious, though the swelling can easily cut off air flow leading to very disabling and threatening conditions.

It’s believed that there is a generic mechanism for lung inflammation by combustion-derived nanoparticles, despite the wide variety of different kinds of chemistry in these particles. All these have in common the production of free radicals, which leads to oxidative stress, which in turn leads to inflammation. DIfferent types of nanoparticles cause oxidative stress through different mechanisms. Metal nanoparticles – as found in welding fumes – yield one mechanism, surface born organics (as are found in soot), have another, and materials like carbon black, titanium dioxide and polystyrene latex, which are not very intrinsically toxic, operate through some generic surface mechanism. Clearly it is the surface area that is important, so nanoparticles cause more inflammation than the same mass of fine respirable particles, in the 2-3 micron range, composed of the same materials. In passing one can note that diesel fumes are particularly harmful, dealing a triple blow through their combination of surfaces, metals and organics. These pathways to oxidative stress are very well understood now, so this is a well-found paradigm.

Inflammation due to the oxidative stress caused by nanoparticles from pollution then leads to a number of different diseases, including cardiovascular diease, asthma, scarring, cancer and chronic obstructive pulmonary disease). Their involvement in cardiovascular disease is perhaps unexpected, and to understand it we need to understand where the nanoparticles go. We have some rather hypothetical toxicokinetics based on a few experiments using radioactive, insoluble tracer particles. Having entered the nose or lung, a few studies suggest that they can go directly to the brain. The route from the lung to the blood is well understood, and once in the blood there are many possible ultimate destinations. It’s doubtful that nanoparticles could enter the blood directly from the gut or skin. A mechanism for the involvement of nanoparticles in cardiovascular disease is suggested by studies in which healthy Swedish student volunteers rode a bike in an atmosphere of diesel fumes (at levels comparable to highly polluted city streets). This leads to measurable vascular dysfunction throughout the whole body, and a reduction in the ability to dissolve blood clots (similar effects will be observed in smokers, who self-administer nanoparticles). This suggests that pollution nanoparticles could cause cardiovascular disease either through lung inflammation or through the direct effect of bloodborn particles, leading to the worsening of coronary artery disease or increased blood clotting.

A study using radioactive carbon has suggested that nanoparticles can enter the brain directly from the nose, via the olfactory bulb – this is the route into the central nervous system used by the polio virus, and it doesn’t required crossing the blood-brain barrier. Studies of brain tissue in people living in highly polluted cities like Mexico City have shown pathological changes simiilar to those seen in victims of Parkinson’s and Alzheimer’s occurring as a result of the effect of pollution-derived nanoparticles.

The potential comparison between carbon nanotubes and asbestos is worth considering. Very large exposures to asbestos in the past have caused many cases of fatal lung disease. The characteristics of asbestos which cause this disease – and these characteristics are physical, not chemical – are that they are thin, persistent in the body, and long. Carbon nanotubes certainly match the first two requirements, but it is not obvious that they fulfill the third. Asbestos fibres need to be 20 microns long to demonstrate toxic effects; if they are milled to shorter lengths the toxicity goes away. Carbon nanotubes of this length tend to curl up and clump. On the other hand rat experiments on the effect of nanotubes on the lungs show distinctive fibrosing lesions. Donaldson has just written an extensive review article about nanotube toxicity which will be published soon.

From the regulatory point of view there are some difficulties as regulations usually specify exposure limits in terms of mass concentration, while clearly it is surface area that is important. In the USA NIOSH thinking of reducing limits by a factor of 5 for ultrafine TiO2. Fibres, though, are regulated by number density. The difficulties for carbon nanotubes are that they are probably too small to see by standard microscopy, and they curl up, so although they should be classifed as fibres by WHO definitions probably aren’t going to be detected. In terms of workplace protection local exhaust ventilation is much the best, with almost all masks being fairly useless. This applies, for example, to the masks used by some cyclists in polluted cities. They can, however, take comfort from the fact that their exposure to nanoparticles is significantly smaller than the exposure of the people inside the vehicles who are causing the pollution.

My conclusion, then, is if you are worried about inhaling free nanoparticles (and you should be) you should stop travelling by car.

Regulatory concerns about nanotechnology and food

The UK Government’s Food Standards Agency has issued a draft report about the use of nanotechnology in food and the regulatory implications this might have. The report can be downloaded here; the draft report is now open for public consultation and comments are invited by July 14th.

Observers could be forgiven some slight bemusement when it comes to the potential applications of nanotechnology to food, in that, entirely according to one’s definition of nanotechnology, these could encompass either almost everything or almost nothing. As the FSA says on its website: “In its widest sense, nanotechnology and nanomaterials are a natural part of food processing and conventional foods, as the characteristic properties of many foods rely upon nanometre sized components (e.g. nanoemulsions and foams).” To give just one example, the major protein component of milk – casein – is naturally present in the form of clusters of molecules tens of nanometers in size, so most of the processes of the dairy industry involve the manipulation of naturally occurring nanoparticles. On the other hand, in terms of the narrow focus that has developed at the applications end of nanotechnology on engineered nanoparticles, the current impact on food is rather small. In fact, the FSA states categorically in the report: “The Agency is not aware of any examples of manufactured nanoparticles or other nanomaterials being used in food currently sold in the UK.”

In terms of the narrow focus on engineered nanoparticles, it is clear that there is indeed a regulatory gap at the moment. The FSA states that, if a food ingredient were to be used in a new, nanoscale form, then currently there would be no need to pass any new regulatory hurdles. However, the FSA believes that a more general protection would step in as a backstop – ” in such cases, the general safety articles of the EU Food Law Regulation (178/2002) would apply, which require that food placed on the market is not unsafe.” So, how likely is it that this situation, and subsequent problems, might arise? One needs first to look at those permitted food additives that are essentially insoluble in oil or water. These include (in the EU) some inorganic materials that have been used in nanoparticulate form in non-food contexts, including titanium dioxide, silicon dioxide, some clay-based materials, and the metals aluminium, silver and gold. Insoluble organic materials include cellulose, in both powdered and microcrystalline forms. The latter is an interesting case because it provides a precedent for regulations that do specify size limits – the FSA report states that ” The only examples in the food additives area that specifically limits the presence of small particles is the specification for microcrystalline cellulose, where the presence of small particles (< 5 microns) is limited because of uncertainties over their safety. " The FSA seems fairly confident that if necessary similar amendments could quickly be made in the case of other materials. But there remains the problem that currently there isn’t, as far as I can see, a fail-safe method by which the FSA could be alerted to the use of such nanomaterials and any problems they might cause. On the other hand, it’s not obvious to me why one might want to use these sorts of materials in a nanoparticulate form in food. Titanium dioxide, for example, is used essentially as a white pigment, so there wouldn’t be any point using it in a transparent, nanoscale form.

Synthetic biology – the debate heats up

Will it be possible to radically remodel living organisms so that they make products that we want? This is the ambition of one variant of synthetic biology; the idea is to take a simple bacteria, remove all unnecessary functions, and then patch the genetic code for the functions we want. It’s clear that this project is likely to lead to serious ethical issues, and the debate about these issues is beginning in earnest today. At a conference being held in Berkeley today, synthetic biology 2.0, the synthetic biology research community is having discussions on biosecurity & risk, public understanding & perception, ownership, sharing & innovation, and community organization, with the aim of developing a framework for the self-regulation of the field. Meanwhile, a coalition of environmental NGOs, including Greenpeace, Genewatch, Friends of the Earth and ETC, has issued a press release calling on the scientists to abandon this attempt at self-regulation.

Some of the issues to be discussed by the scientists can be seen on this wiki. One very prominent issue is the possibility that malevolent groups could create pathogenic organisms using synthetic DNA, and there is a lot of emphasis on what safeguards can be put in place by the companies that supply synthetic DNA with a specified sequence. This is a very important problem – the idea that it is now possible to create from scratch pathogens like the virus behind the 1918 Spanish flu pandemic frightens many people, me included. But it’s not going to be the only issue to arise, and I think it is very legitimate to wonder whether community self-regulation is sufficient to police such a potentially powerful technology. The fact that much of the work is going on in commercial organisations is a cause for concern. One of the main players in this game is Synthetic Genomics, inc, which was set up by Craig Venter, who already has some form in the matter of not being bound by the consensus of the scientific community.

In terms of the rhetoric surrounding the field, I’d also suggest that the tone adopted in articles like this one, in this weeks New Scientist, Redesigning life: Meet the biohackers (preview, subscription required for full article), is unhelpful and unwise, to say the least.

Nanoparticle toxicity: The Royal Society bites back

Last week saw a little bit more bad publicity for the nascent nano industry, in the shape of a news report from the BBC highlighting a call from the Royal Society for industry to disclose the data from its safety testing of free nanoparticles in consumer products. The origin of the report was a press release from the Royal Society, quoting Ann Dowling, the chair of the Royal Society/Royal Academy of Engineering study of nanotechnology.

The pretext for the Royal Society press release was the recent publication of an inventory of consumer products using nanotechnology by the Woodrow Wilson Centre Project on Emerging Nanotechnologies. But this call for disclosure was already one of the recommendations in the Royal Society’s report, and it’s not hard to sense the growing frustration within the Royal Society that, two years on from the publication of that report, we’re not much further forward in implementing many of its recommendations.